Go back to News
NEWS
GA_P advises Vista Equity Partners on €2.425m acquisition of Duck Creek
10 of January, 2023
GA_P has advised investment fund Vista Equity Partners on the Spanish leg of the acquisition of Duck Creek Technologies (NASDAQ: DCT) to delist it from the stock exchange.
Vista Equity Partners has reached an agreement with technology company Duck Creek Technologies to acquire it for a total of $2.6 billion (€2.425 billion) in cash. The deal is expected to close in the second quarter of 2023, subject to the satisfaction of certain conditions customary in such transactions, after which the entity will be delisted.
Duck Creek specialises in providing customer management software products to insurance companies and broker-dealers.
Vista Equity Partners is a leading global investment fund investing in enterprise software, data and technology companies.
They advised on the transaction: Alex Pujol, partner of Commercial, Andrea Esbrí, senior associate of Commercial, Mònica Martells, associate of Commercial, and Anna Viladás and Paula Ruiz Cotorro from Industrial Property, Intellectual Property and Technology.
Vista Equity Partners has reached an agreement with technology company Duck Creek Technologies to acquire it for a total of $2.6 billion (€2.425 billion) in cash. The deal is expected to close in the second quarter of 2023, subject to the satisfaction of certain conditions customary in such transactions, after which the entity will be delisted.
Duck Creek specialises in providing customer management software products to insurance companies and broker-dealers.
Vista Equity Partners is a leading global investment fund investing in enterprise software, data and technology companies.
They advised on the transaction: Alex Pujol, partner of Commercial, Andrea Esbrí, senior associate of Commercial, Mònica Martells, associate of Commercial, and Anna Viladás and Paula Ruiz Cotorro from Industrial Property, Intellectual Property and Technology.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
07 Apr, 2025 
PUBLICATION
2 days ago
Pharma & Healthcare No. 43
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
2 days ago 
PUBLICATION
27 Mar, 2025
The notion of ‘pharmacological action’ in the legal concept of medicinal product
A look at the judgment of the Court of Justice in Case C-589/23, Cassella-med and MCM Klosterfrau, ECLI:EU:C:2025:173.
27 Mar, 2025
PUBLICATION
25 Mar, 2025
A first ranking mortgage does not prevent a creditor from accelerating loan maturity due to debtor insolvency
If the creditor has a secured claim (even if the debt is covered by the "value of the security", i.e. the claim is in the money), the debtor cannot avoid the effects of the to-term forfeiture by appealing to the existence of that security because the guarantee referred to in Article 1129(1) of the Civil Code (avoiding to-term forfeiture) must then be another additional guarantee.
25 Mar, 2025
PUBLICATION
25 Mar, 2025
La existencia de una hipoteca de primer rango no impide que el acreedor pueda declarar el vencimiento anticipado del plazo por insolvencia sobrevenida del deudor
Si el acreedor goza de una garantía real para la seguridad de su crédito (incluso si la deuda está cubierta por el «valor de la garantía», es decir, que el crédito está in the money), el deudor no puede evitar los efectos de la pérdida del plazo apelando a la existencia de aquella garantía real porque la garantía a que se refiere el artículo 1129.1.º del Código Civil (evitadora de la pérdida del plazo) deberá ser entonces otra garantía suplementaria.
25 Mar, 2025
PUBLICATION
20 Mar, 2025
Use of environmental claims in advertising: the Iberdrola v. Repsol case
Santander Companies Court No. 2 Judgment no. 12/2025 of 21 February, which is not conclusive, is analysed.
20 Mar, 2025
PUBLICATION
14 Mar, 2025
A good ruling on financial assistance: collateral given to secure third-party borrowings is not invalid
This latest Supreme Court ruling on the prohibition of financial assistance in the purchase of shares in the assisting company (assisting as ‘borrower for third party debt’) is to be praised, erasing the bad taste left by the reading of the immediate precedent (Supreme Court Judgment of 20 April 2023, Ezentis) which held an agreement to underwrite the value of the shares sold by the company invalid.
14 Mar, 2025
PUBLICATION
10 Mar, 2025
Pharma & Healthcare No. 42
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
10 Mar, 2025
PUBLICATION
07 Feb, 2025
New obligation to make health data available to third parties: issues with protected data
This paper explores the new obligation to make health data available to third parties in light of the Regulation of the European Parliament and of the Council on the European Health Data Space.
07 Feb, 2025
PUBLICATION
29 Jan, 2025
Medidas y prórroga de medidas laborales y de seguridad social a la espera de los Presupuestos Generales del Estado
Ante la ausencia de Presupuestos Generales del Estado, se aprueban medidas urgentes que, en el ámbito laboral y de la Seguridad Social, permiten actualizar algunas cuantías y aplicar algunas normas previstas para el 2025.
29 Jan, 2025